Sue Sutter

Senior Editor

Washington, D.C.

Sue is a senior editor with Pink Sheet, where she writes primarily about drug, biologic and biosimilar regulation, FDA advisory committees and product approvals. She has reported on the prescription and over-the-counter drug industries since 1999 for various publications now under the umbrella of Informa Business Information, including Pink Sheet, “The Pink Sheet” DAILY, “The Tan Sheet” and Scrip. Previously she worked as an editor for Mealey’s Litigation Reports (now part of Lexis-Nexis), writing about asbestos, toxic tort and fen-phen litigation.

Areas of Expertise: Legal Issues Regulation
Industry Experience: BioPharmaceutical
Writes for: Pink Sheet Scrip

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Sue Sutter

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Sue Sutter

Senior Editor

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Email Author

Sign In To Set a Search Alert